SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pisters PW, Ranson JH. Nutritional support for acute pancreatitis. Surg. Gynecol. Obstet. 1992; 175: 27584.
  • 2
    British Society of Gastroenterology. United Kingdom guidelines for the management of acute pancreatitis. British Society of Gastroenterology. Gut 1998; 42: S113.
  • 3
    Chandrasegaram MD, Plank LD, Windsor JA. The impact of total parenteral nutrition on the body composition of patients with acute pancreatitis. JPEN J. Parenter. Enteral Nutr. 2005; 29: 6573.
  • 4
    Gupta R, Patel K, Calder PC, Yaqoob P, Primrose JN, Johnson CD. A randomized clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis. Pancreatology 2003; 3: 40613.
  • 5
    Eatock FC, Brombacher GD, Steven A, Imrie CW, McKay CJ, Carter R. Nasogastric feeding in severe acute pancreatitis may be practical and safe. Int. J. Pancreatol. 2000; 28: 239.
  • 6
    Abous-Assi S, Craig K, O'Keefe SJ. Hypocaloric feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study. Am. J. Gastroenterol. 2002; 97: 225562.
    Direct Link:
  • 7
    Windsor JA. Search for prognostic markers for acute pancreatitis. Lancet 2000; 355: 19245.
  • 8
    Levy P, Heresbach D, Pariente EA et al. Frequency and risk factors of recurrent pain during refeeding in patients with acute pancreatitis: a multivariate multicentre prospective study of 116 patients. Gut 1997; 40: 2626.
  • 9
    Pandey SK, Ahuja V, Joshi YK, Sharma MP. A randomized trial of oral refeeding compared with jejunal tube refeeding in acute pancreatitis. Ind. J. Gastroenterol. 2004; 23: 535.
  • 10
    Chelbi JMF, Gaburri PD, De Souza AFM et al. Oral refeeding in patients with mild acute pancreatitis: Prevalence and risk factors of relapsing abdominal pain. J. Gastroenterol. Hepatol. 2005; 20: 13851389.
  • 11
    Levy P, Arotcavena R, Bartolie E et al. Efficacy of lanreotide 30 mg on prevention of pain relapse after oral refeeding in patients with necrotizing acute pancreatitis: a Phase II prospective multicentre study. Pancreatology 2004; 4: 22932.